SCHEMBL8907847

SCHEMBL8907847

CC1(C)CCC(C)(C)c2cc(C(N)COc3ccc(C(=O)O)c(O)c3)ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 4/20 0.55
CYP3A4 P08684 3/20 0.55
CYP26B1 Q9NR63 3/20 0.55
RXRA P19793 5/20 0.46
RXRB P28702 3/20 0.46
RARA P10276 5/20 0.45
RARB P10826 5/20 0.45
RARG P13631 5/20 0.45
PPARG P37231 2/20 0.44
RXRG P48443 2/20 0.42
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
GRM1 Q13255 2/20 0.40
GRM2 Q14416 2/20 0.40
MEN1 O00255 1/20 0.40
CYP2C9 P11712 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5084224 0.88 CYP26A1 (0.72) CYP26A1CYP3A4CYP26B1RXRARXRB
SCHEMBL8907780 0.87 CYP3A4 (0.47) CYP26A1CYP3A4CYP26B1RXRARXRB
SCHEMBL5078196 0.84 CYP26A1 (0.53) CYP26A1CYP3A4CYP26B1RXRARXRB
SCHEMBL9194524 0.83 CYP26A1 (0.51) CYP26A1CYP3A4CYP26B1RXRARXRB
SCHEMBL8908988 0.80 CYP3A4 (0.64) CYP26A1CYP3A4CYP26B1RXRARXRB
SCHEMBL8907781 0.79 MAOB (0.53) CYP26A1CYP3A4CYP26B1RXRARXRB
SCHEMBL9191681 0.79 CYP26A1 (0.48) CYP26A1CYP3A4CYP26B1RXRARXRB
SCHEMBL8907733 0.78 CYP26A1 (0.52) CYP26A1CYP3A4CYP26B1RXRARXRB
SCHEMBL5084222 0.77 CYP3A4 (0.63) CYP26A1CYP3A4CYP26B1RXRARXRB
SCHEMBL9193669 0.77 CYP26A1 (0.56) CYP26A1CYP3A4CYP26B1RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0514264-B1 Biaromatic compounds derived from compounds having a salicylic configuration, their preparation process and their use in human and veterinary medicine and in cosmetics CIRD GALDERMA (FR) 1995-11-15 EP claimed
US-5654331-A SKIN AND RESPIRATORY SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS; ANTIALLERGENS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1997-08-05 US disclosed
US-5476860-A Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (CIRD GALDERMA) (FR) 1995-12-19 US disclosed
EP-0514264-B1 Biaromatic compounds derived from compounds having a salicylic configuration, their preparation process and their use in human and veterinary medicine and in cosmetics CIRD GALDERMA (FR) 1995-11-15 EP disclosed
WO-1992020643-A1 NOVEL BI-AROMATIC COMPOUNDS DERIVED FROM A SALICILIC PATTERN, METHOD OF PREPARATION AND USE IN HUMAN AND VETERINARY MEDECINE AND IN COSMETICS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1992-11-26 WO disclosed
EP-0514264-A1 Biaromatic compounds derived from compounds having a salicylic configuration, their preparation process and their use in human and veterinary medicine and in cosmetics CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) 1992-11-19 EP disclosed